Copyright
©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1377-1384
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1377
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1377
Treatment group (n = 64) | Control group (n = 64) | P value | |
Age (yr) | 46.3 ± 11.2 | 45.6 ± 10.8 | 0.68 |
Sex (male/female) | 32/32 | 33/31 | 0.82 |
Body mass index (kg/m2) | 23.5 ± 3.2 | 23.7 ± 3.4 | 0.76 |
Duration of disease (months) | 27.4 ± 15.6 | 26.8 ± 16.2 | 0.84 |
Helicobacter pylori status (positive/negative) | 38/26 | 37/27 | 0.88 |
NDI score | 42.7 ± 8.9 | 43.1 ± 9.2 | 0.79 |
MLS score | 6.4 ± 2.1 | 6.5 ± 2.2 | 0.87 |
USS score | 9.3 ± 3.4 | 9.5 ± 3.6 | 0.81 |
Microcosmic syndrome score | 12.6 ± 4.8 | 12.8 ± 4.9 | 0.83 |
- Citation: Bai CY, Tian W, Zhang Q. Clinical study on microscopic syndrome differentiation and traditional Chinese medicine treatment for liver stomach disharmony in chronic gastritis. World J Gastrointest Surg 2024; 16(5): 1377-1384
- URL: https://www.wjgnet.com/1948-9366/full/v16/i5/1377.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i5.1377